These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31753191)

  • 1. How It Works: The Immunology Underlying Phototherapy.
    Yu Z; Wolf P
    Dermatol Clin; 2020 Jan; 38(1):37-53. PubMed ID: 31753191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the immunological mechanism of action behind phototherapy.
    Tartar D; Bhutani T; Huynh M; Berger T; Koo J
    J Drugs Dermatol; 2014 May; 13(5):564-8. PubMed ID: 24809879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phototherapy in psoriasis: a review of mechanisms of action.
    Wong T; Hsu L; Liao W
    J Cutan Med Surg; 2013; 17(1):6-12. PubMed ID: 23364144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distinct role and regulatory mechanism of IL-17 and IFN-γ in the initiation and development of plaque vs guttate psoriasis.
    Yan K; Han L; Deng H; Fang X; Zhang Z; Huang G; Zheng ZZ; Huang Q; Xu J
    J Dermatol Sci; 2018 Oct; 92(1):106-113. PubMed ID: 30072243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder.
    Singh TP; Schön MP; Wallbrecht K; Michaelis K; Rinner B; Mayer G; Schmidbauer U; Strohmaier H; Wang XJ; Wolf P
    J Immunol; 2010 Jun; 184(12):7257-67. PubMed ID: 20488788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current developments in phototherapy for psoriasis.
    Morita A
    J Dermatol; 2018 Mar; 45(3):287-292. PubMed ID: 29369396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phototherapy of Psoriasis, a Chronic Inflammatory Skin Disease.
    Rácz E; Prens EP
    Adv Exp Med Biol; 2017; 996():287-294. PubMed ID: 29124709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards optimal regimens for the UVB phototherapy of psoriasis: a mathematical model.
    Diffey BL
    Acta Derm Venereol; 2004; 84(4):259-64. PubMed ID: 15339068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Pathophysiological Targets of Psoriasis for Future Therapeutic Strategies.
    Yadav M; Sardana I; Sharma A; Sharma N; Nagpal K; Malik P
    Infect Disord Drug Targets; 2020; 20(4):409-422. PubMed ID: 31288731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The immunology of psoriasis: from basic research to the bedside].
    Gyulai R; Kemény L
    Orv Hetil; 2006 Nov; 147(46):2213-20. PubMed ID: 17396393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between keratinocytes and immune cells--recent insights into psoriasis pathogenesis.
    Tonel G; Conrad C
    Int J Biochem Cell Biol; 2009 May; 41(5):963-8. PubMed ID: 19027868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Early Immunomodulatory Triggers to Immunosuppressive Outcome: Therapeutic Implications of the Complex Interplay Between the Wavebands of Sunlight and the Skin.
    Vieyra-Garcia PA; Wolf P
    Front Med (Lausanne); 2018; 5():232. PubMed ID: 30250844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of phototherapy, adalimumab and betamethasone-calcipotriol on effector and regulatory T cells in psoriasis.
    Kotb IS; Lewis BJ; Barker RN; Ormerod AD
    Br J Dermatol; 2018 Jul; 179(1):127-135. PubMed ID: 29330859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
    Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
    J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin.
    Piskin G; Sylva-Steenland RM; Bos JD; Teunissen MB
    J Immunol; 2006 Feb; 176(3):1908-15. PubMed ID: 16424222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local effects of TL01 phototherapy in psoriasis.
    DeSilva B; McKenzie RC; Hunter JA; Norval M
    Photodermatol Photoimmunol Photomed; 2008 Oct; 24(5):268-9. PubMed ID: 18811869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis.
    Wolk K; Witte K; Witte E; Raftery M; Kokolakis G; Philipp S; Schönrich G; Warszawska K; Kirsch S; Prösch S; Sterry W; Volk HD; Sabat R
    Sci Transl Med; 2013 Sep; 5(204):204ra129. PubMed ID: 24068736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of regulatory T cells in the pathogenesis of psoriasis: review of the literature.
    Mattozzi C; Salvi M; D'Epiro S; Giancristoforo S; Macaluso L; Luci C; Lal K; Calvieri S; Richetta AG
    Dermatology; 2013; 227(2):134-45. PubMed ID: 24051528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
    Lovato P; Norsgaard H; Tokura Y; Røpke MA
    J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.
    Oka T; Sugaya M; Takahashi N; Takahashi T; Shibata S; Miyagaki T; Asano Y; Sato S
    J Immunol; 2017 May; 198(10):3897-3908. PubMed ID: 28389593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.